| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:SOS1-IN-3
CAS:2359689-76-0
Package:100mg/RMB 17500;50mg/RMB 13800;25mg/RMB 10600
|
Pyrido[4,3-d]pyrimidin-7(6H)-one, 4-[[(1R)-1-[3-(difluoromethyl)-2-fluorophenyl]ethyl]amino]-2-methyl-6-(1-methylcyclopropyl)- manufacturers
- SOS1-IN-3
-
- $2500.00 / 100mg
-
2025-10-27
- CAS:2359689-76-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Pyrido[4,3-d]pyrimidin-7(6H)-one, 4-[[(1R)-1-[3-(difluoromethyl)-2-fluorophenyl]ethyl]amino]-2-methyl-6-(1-methylcyclopropyl)- Basic information |
| | Pyrido[4,3-d]pyrimidin-7(6H)-one, 4-[[(1R)-1-[3-(difluoromethyl)-2-fluorophenyl]ethyl]amino]-2-methyl-6-(1-methylcyclopropyl)- Chemical Properties |
| Boiling point | 492.0±55.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | pka | 10.10±0.20(Predicted) |
| | Pyrido[4,3-d]pyrimidin-7(6H)-one, 4-[[(1R)-1-[3-(difluoromethyl)-2-fluorophenyl]ethyl]amino]-2-methyl-6-(1-methylcyclopropyl)- Usage And Synthesis |
| Uses | SOS1-IN-3 is a potent SOS1 (son of sevenless homolog 1) inhibitor with an IC50 of 5 nM. SOS1-IN-3 has anticancer effects (WO2019122129A1; compound I-1)[1]. | | References | [1] Juergen Ramharter, et al. Novel benzylamino substituted pyridopyrimidinones and derivatives as sos1 inhibitors. WO2019122129A1 |
| | Pyrido[4,3-d]pyrimidin-7(6H)-one, 4-[[(1R)-1-[3-(difluoromethyl)-2-fluorophenyl]ethyl]amino]-2-methyl-6-(1-methylcyclopropyl)- Preparation Products And Raw materials |
|